Charts
On The Pen With Dave KnappEpisode from the podcastOn The Pen With Dave Knapp
Next Episode
Eli Lilly Earnings Call Recap: Stock Tanks on Weight Loss Pill Miss

Eli Lilly Earnings Call Recap: Stock Tanks on Weight Loss Pill Miss

Released Thursday, 7th August 2025
Good episode? Give it some love!
Eli Lilly Earnings Call Recap: Stock Tanks on Weight Loss Pill Miss

Eli Lilly Earnings Call Recap: Stock Tanks on Weight Loss Pill Miss

Eli Lilly Earnings Call Recap: Stock Tanks on Weight Loss Pill Miss

Eli Lilly Earnings Call Recap: Stock Tanks on Weight Loss Pill Miss

Thursday, 7th August 2025
Good episode? Give it some love!
Rate Episode
List
About
InsightsPodchaser Pro
Reviews
Credits
Lists
Transcript

VISIT ALL OUR LINKS:
https://linktr.ee/manonthemounjaro

📩 Subscribe to On The Pen on Substack for breaking GLP-1 news and advocacy:
https://onthepen.substack.com

Show More
Rate
List
Get this podcast via API

From The Podcast

1
Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more
Do you host or manage this podcast?
Claim and edit this page to your liking.
,
Podchaser Logo

Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More